Balance Sheet
Cash Flow Statement
AmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Change in Account Payables (2016 - 2025)

MediWound has reported Change in Account Payables over the past 13 years, most recently at -$59000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 102.51% year-over-year to -$59000.0; the TTM value through Dec 2025 reached $2.4 million, up 478.82%, while the annual FY2025 figure was $2.4 million, 478.82% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$59000.0 at MediWound, down from $1.7 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $2.4 million in Q4 2024 and troughed at -$1.4 million in Q1 2024.
  • A 5-year average of $277800.0 and a median of $277500.0 in 2021 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: plummeted 720.36% in 2024 and later surged 3679.17% in 2025.
  • Year by year, Change in Account Payables stood at $990000.0 in 2021, then fell by 20.81% to $784000.0 in 2022, then soared by 39.41% to $1.1 million in 2023, then skyrocketed by 115.37% to $2.4 million in 2024, then tumbled by 102.51% to -$59000.0 in 2025.
  • Business Quant data shows Change in Account Payables for MDWD at -$59000.0 in Q4 2025, $1.7 million in Q3 2025, and $794000.0 in Q2 2025.